InvestSMART

Cynata Therapeutics Limited (ASX: CYP) - Announcements

- Current share price for CYP : $0.011

ASX company news and announcements for Cynata Therapeutics Limited (CYP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Cynata Therapeutics Limited (CYP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Cynata Therapeutics Limited (CYP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Cynata Therapeutics Limited (CYP)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$3 Cynata Advances Clinical Trial in Diabetic Foot Ulcers 21 Apr 2022 9:23AM $0.390 $0.011 fallen by 97.18%
$3 Updated Investor Presentation 8 Mar 2022 9:07AM $0.430 $0.011 fallen by 97.44%
$3 Notice of Allowance for Cynata Chinese Patent 28 Feb 2022 9:30AM $0.420 $0.011 fallen by 97.38%
$3 Appendix 4D & Half-Year Financial Statements 25 Feb 2022 2:59PM $0.420 $0.011 fallen by 97.38%
$3 Quarterly Activity Report & Appendix 4C 28 Jan 2022 3:15PM $0.480 $0.011 fallen by 97.71%
$3 Cynata Receives Decision to Grant a Patent in Japan 27 Jan 2022 9:25AM $0.475 $0.011 fallen by 97.68%
$3 Cynata Receives $832,677 R&D Tax Incentive Refund 19 Jan 2022 9:24AM $0.550 $0.011 fallen by 98%
$3 FUJIFILM Cellular Dynamics Executes Manufacturing Agreement 29 Dec 2021 9:32AM $0.480 $0.011 fallen by 97.71%
$3 Cynata Commences DFU Clinical Trial 22 Dec 2021 8:43AM $0.450 $0.011 fallen by 97.56%
$3 Change of Registry Address 20 Dec 2021 2:26PM $0.460 $0.011 fallen by 97.61%
$3 Appendix 3Y- Dr Stewart Washer 2 Dec 2021 2:34PM $0.500 $0.011 fallen by 97.80%
$3 Appendix 3Y - Dr Geoffrey Brooke 1 Dec 2021 12:05PM $0.500 $0.011 fallen by 97.80%
$3 Site Initiation Visit Completed for CYP DFU Clinical Trial 18 Nov 2021 9:20AM $0.530 $0.011 fallen by 97.92%
$3 Results of Annual General Meeting 16 Nov 2021 1:55PM $0.550 $0.011 fallen by 98%
$3 AGM Presentations 16 Nov 2021 9:48AM $0.545 $0.011 fallen by 97.98%
$3 Quarterly Activity Report & Appendix 4C 28 Oct 2021 12:42PM $0.600 $0.011 fallen by 98.17%
$3 Cynata Receives US$5m Fujifilm Fee 18 Oct 2021 9:33AM $0.630 $0.011 fallen by 98.25%
$3 Annual Report to shareholders 14 Oct 2021 5:17PM $0.610 $0.011 fallen by 98.20%
$3 Letter to Shareholders & Notice of Annual General Meeting 14 Oct 2021 5:07PM $0.610 $0.011 fallen by 98.20%
$3 Notification regarding unquoted securities - CYP 12 Oct 2021 5:13PM $0.610 $0.011 fallen by 98.20%
$3 DSMB Recommends Continuation of Cynata's MEND Trial 8 Oct 2021 9:23AM $0.625 $0.011 fallen by 98.24%
$3 Cynata Enters into a New Strategic Partnership with Fujifilm 30 Sep 2021 2:02PM $0.550 $0.011 fallen by 98%
$3 CYP Preclinical Heart Attack Study Published in Cytotherapy 28 Sep 2021 9:29AM $0.525 $0.011 fallen by 97.90%
$3 Date of AGM and Closing Date for Director Nominations 21 Sep 2021 4:48PM $0.510 $0.011 fallen by 97.84%
$3 Further Patents for Cynata Unique Cymerus Technology 15 Sep 2021 12:38PM $0.540 $0.011 fallen by 97.96%

251 - 275 of 708 results

Page 11 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.